Sign-in Help

Data protection and life sciences

View Life Sciences by content type:

Practice notes
Precedents
Q&As

Featured Life Sciences content

Brexit legislation tracker

Brexit legislation tracker

This Practice Note tracks the progress of UK legislation introduced as part of the legislative project associated with the UK’s withdrawal from the

Deeds

Deeds

Under English law legally binding agreements can be made orally, in writing or by deed.This Practice Notice considers the circumstances in which a

Arbitration—an introduction to the key features of arbitration

Arbitration—an introduction to the key features of arbitration

This Practice Note provides an introduction to arbitration and its key features, with a particular focus on arbitration under the law of England and

An introduction to the regulation of medicinal products

An introduction to the regulation of medicinal products

On 31 January 2020, the UK ceased to be an EU Member State and entered an implementation period during which it continues to be treated by the EU as a

Practice notes

Major types of patent claims

IntroductionPatent claims may be separated into two broad categories: product claims and process claims. Product claims and process claims are...
Read More >
Produced in partnership with Bristows LLP 30th Oct
Practice notes

The General Data Protection Regulation—application in the life sciences sector

BREXIT: On 31 January 2020, the UK ceased to be an EU Member State and entered an implementation period, during which it continues to be subject to EU...
Read More >
Produced in partnership with Elinor Pecsteen and Cristiana Spontoni of Jones Day (Brussels) 19th Oct
Practice notes

Introduction to patents

This Practice Note provides an introduction to:•what is a patent?•applying for and maintaining patents•dealing with patents in agreements•patent...
Read More >
16th Oct
Practice notes

mHealth—data protection considerations

BREXIT: On 31 January 2020, the UK ceased to be an EU Member State and entered an implementation period, during which it continues to be subject to EU...
Read More >
26th Sep
Practice notes

Regulation of e-cigarettes

What are e-cigarettes?Electronic cigarettes (commonly known as ‘e-cigarettes’, ‘vapourisers’ or ‘vapes’) are products that can be used to consume...
Read More >
26th Sep
Practice notes

Intellectual property protection for medical devices

On 31 January 2020, the UK ceased to be an EU Member State and entered an implementation period during which it continues to be treated by the EU as a...
Read More >
26th Sep
Practice notes

Life sciences—new starter guide

This new starter guide provides an introduction to the life sciences practice area, the legislative and regulatory framework which governs the life...
Read More >
26th Sep
Practice notes

Conducting clinical research—data protection implications

BREXIT: On 31 January 2020, the UK ceased to be an EU Member State and entered an implementation period, during which it continues to be subject to EU...
Read More >
26th Sep
Practice notes

Unlicensed medicinal products and off-label use of medicinal products

On 31 January 2020, the UK ceased to be an EU Member State and entered an implementation period during which it continues to be treated by the EU as a...
Read More >
26th Sep
Practice notes

Clinical trials

On 31 January 2020, the UK ceased to be an EU Member State and entered an implementation period during which it continues to be treated by the EU as a...
Read More >
26th Sep
Practice notes

Pharmaceutical pricing and reimbursement

On 31 January 2020, the UK ceased to be an EU Member State and entered an implementation period during which it continues to be treated by the EU as a...
Read More >
26th Sep
Practice notes

Second and subsequent medical use patent claims

Background to medical use claimsSecond (and subsequent) medical use patent claims are specific to the pharmaceutical/biotechnology industry and are...
Read More >
26th Sep
Practice notes

The experimental use and Bolar-type exemptions to patent infringement

On 31 January 2020, the UK ceased to be an EU Member State and entered an implementation period during which it continues to be treated by the EU as a...
Read More >
26th Sep
tag iconIn-house
Practice notes

Marketing authorisations—regulatory procedures for approval of medicinal products

On 31 January 2020, the UK ceased to be an EU Member State and entered an implementation period during which it continues to be treated by the EU as a...
Read More >
25th Sep
Practice notes

Biotechnology patents

On 31 January 2020, the UK ceased to be an EU Member State and entered an implementation period during which it continues to be treated by the EU as a...
Read More >
25th Sep
Practice notes

Advertising and promotion of medicinal products

This Practice Note introduces and considers the general principles that apply to the advertising and promotion of medicinal products as well as the...
Read More >
25th Sep

Most recent Data protection and life sciences content

Practice notes

Conducting clinical research—data protection implications

BREXIT: On 31 January 2020, the UK ceased to be an EU Member State and entered an implementation period, during which it continues to be subject to EU...
Read More >
26th Sep
Practice notes

mHealth—data protection considerations

BREXIT: On 31 January 2020, the UK ceased to be an EU Member State and entered an implementation period, during which it continues to be subject to EU...
Read More >
26th Sep
Q&As

Are biological samples treated as ‘personal data’ under EU Directive 95/46/EC and the UK Data Protection Act 1998?

Directive 95/46/EC (Directive)Article 2 of Directive 95/46/EC (Directive) provides that ‘personal data’ is information relating to an identified or...
Read More >
28th Sep
Q&As

Which laws and regulations govern health care apps (mHealth)?

Regulation as a medical deviceAn app may, depending on the specific characteristics and intended use, fall within the definition of a medical device....
Read More >
28th Sep
Q&As

How does the General Data Protection Regulation affect the pharmacovigilance sector?

Pharmacovigilance (PV) is the practice of monitoring the effects of medicinal drugs after they have been licensed for use to identify and evaluate...
Read More >
Produced in partnership with Rishi Wadwha of International Association of Privacy Professionals 28th Sep
Practice notes

Mobile app development and data protection

Brexit: On 31 January 2020, the UK ceased to be an EU Member State and entered an implementation period, during which it continues to be subject to EU...
Read More >
16th Oct
Q&As

Following the UK ceasing to be a member of the EU in 2019, to what extent may a UK company processing personal data relating to EU nationals on behalf of a data controller based in the EU be subject to EU laws (eg the General Data Protection Regulation and potential fines from EU regulators) as well as UK law; and might additional consent(s) be required from, or additional notification(s) need to be given too, the relevant data subjects for such processing to continue?

The General Data Protection Regulation, Regulation (EU) 2016/679 (GDPR) is an EU regulation that will come into force automatically in the UK on 25...
Read More >
19th Oct
Practice notes

The General Data Protection Regulation—application in the life sciences sector

BREXIT: On 31 January 2020, the UK ceased to be an EU Member State and entered an implementation period, during which it continues to be subject to EU...
Read More >
Produced in partnership with Elinor Pecsteen and Cristiana Spontoni of Jones Day (Brussels) 19th Oct

Popular documents

LEXISNEXIS

Drafting the particulars of claim and reply

This Practice Note provides guidance on the interpretation and application of the relevant provisions of the CPR. Depending on the court in which your matter is proceeding, you may also need to be mindful of additional provisions—see further below.You should also consider if the proceedings will be

LEXISNEXIS

Nuisance and the rule in Rylands v Fletcher—common law liability for pollution

Private nuisancePrivate nuisance is an unlawful interference with a person's use or enjoyment of land or some right over or in connection with it. Interference must be unreasonable, and may be caused, eg by water, smoke, smell, fumes, gas, noise, heat or vibrations. Where the defendant has not

LEXISNEXIS

Claims for use and occupation, mesne profits, double rent and double value

This Practice Note provides guidance on claims for ‘use and occupation’ or mesne profits, and how and when double rent or double value can be claimed.Claims for use and occupationA claim for use and occupation is possible where there is occupation of land without an express agreement fixing the

LEXISNEXIS

Sources of Shari'ah

IntroductionShari'ah (also Sharia, Shariah or Shari’a) (literally, in Arabic, 'the path towards the watering place') or Islamic law is the legal system of the religion of Islam that sets out a system of duties or code of conduct for individuals to follow so that they may live their life in a